While it has been demonstrated that both CaSR and TRPC6 are upregulated in PASMC from IPAH patients and animals with experimental pulmonary hypertension and play a critical role in the pathogenesis of PAH, it remains unknown how this is achieved. The gene discussed is CASR; the disease is pulmonary arterial hypertension.